tiprankstipranks
Trending News
More News >
AFT Pharmaceuticals Ltd. (AU:AFP)
ASX:AFP
Australian Market

AFT Pharmaceuticals Ltd. (AFP) Income Statement

Compare
6 Followers

AFT Pharmaceuticals Ltd. Income Statement

Last quarter (Q4 2025), AFT Pharmaceuticals Ltd.'s total revenue was $121.31M, an increase of 33.47% from the same quarter last year. In Q4, AFT Pharmaceuticals Ltd.'s net income was $14.15M. See AFT Pharmaceuticals Ltd.’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 205.49M$ 194.03M$ 156.64M$ 130.31M$ 113.11M
Gross Profit
$ 89.19M$ 86.89M$ 72.98M$ 61.77M$ 48.74M
Operating Expenses
$ 77.49M$ 66.58M$ 53.31M$ 41.39M$ 38.03M
Depreciation and Amortization
$ 2.67M$ 2.01M$ 1.72M$ 1.04M$ 1.10M
EBITDA
$ 21.52M$ 27.72M$ 20.40M$ 22.16M$ 12.43M
Operating Income
$ 11.70M$ 20.32M$ 19.67M$ 20.39M$ 10.71M
Other Income/Expenses
$ 4.33M$ 1.70M$ -3.87M$ -1.70M$ -2.82M
Pretax Income
$ 16.03M$ 22.02M$ 15.80M$ 18.68M$ 7.89M
Net Income
$ 11.96M$ 15.61M$ 10.65M$ 19.85M$ 7.78M
Per Share Metrics
Basic EPS
$ 0.11$ 0.15$ 0.10$ 0.19$ 0.07
Diluted EPS
$ 0.11$ 0.15$ 0.10$ 0.19$ 0.08
Weighted Average Shares Outstanding
104.87M 104.87M 104.87M 104.87M 104.87M
Weighted Average Shares Outstanding (Diluted)
104.87M 104.87M 104.87M 104.87M 104.87M
Currency in NZD

AFT Pharmaceuticals Ltd. Earnings and Revenue History